Virtus Advisers LLC bought a new stake in shares of Oracle Corporation (NYSE:ORCL – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 1,039 shares of the enterprise software provider’s stock, valued at approximately $227,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Snider Financial Group lifted its holdings in Oracle by 1.3% in the second quarter. Snider Financial Group now owns 3,204 shares of the enterprise software provider’s stock valued at $701,000 after acquiring an additional 40 shares during the period. SNS Financial Group LLC grew its stake in shares of Oracle by 0.9% during the 2nd quarter. SNS Financial Group LLC now owns 4,896 shares of the enterprise software provider’s stock valued at $1,070,000 after purchasing an additional 42 shares during the period. PKS Advisory Services LLC increased its position in shares of Oracle by 1.9% during the 2nd quarter. PKS Advisory Services LLC now owns 2,211 shares of the enterprise software provider’s stock valued at $483,000 after purchasing an additional 42 shares during the last quarter. Reyes Financial Architecture Inc. lifted its stake in shares of Oracle by 7.2% in the 2nd quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider’s stock worth $141,000 after purchasing an additional 43 shares during the period. Finally, Creative Capital Management Investments LLC lifted its stake in shares of Oracle by 5.7% in the 2nd quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider’s stock worth $174,000 after purchasing an additional 43 shares during the period. 42.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ORCL has been the subject of several recent research reports. Baird R W upgraded shares of Oracle to a “strong-buy” rating in a research report on Wednesday, October 8th. Stephens lifted their price target on shares of Oracle from $208.00 to $331.00 and gave the stock an “equal weight” rating in a research note on Friday, October 17th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $375.00 price objective on shares of Oracle in a research report on Wednesday. Erste Group Bank cut Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Finally, Weiss Ratings downgraded Oracle from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, November 25th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have given a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $324.89.
Insider Buying and Selling
In other news, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction that occurred on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the sale, the insider owned 132,656 shares in the company, valued at $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William G. Parrett sold 11,500 shares of the company’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the transaction, the director owned 17,764 shares of the company’s stock, valued at approximately $5,435,784. This represents a 39.30% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 204,254 shares of company stock worth $60,227,807 in the last quarter. 40.90% of the stock is owned by insiders.
Oracle Trading Down 1.7%
Shares of Oracle stock opened at $201.57 on Monday. The company has a market capitalization of $574.62 billion, a P/E ratio of 46.66, a P/E/G ratio of 2.96 and a beta of 1.51. The company has a debt-to-equity ratio of 3.33, a quick ratio of 0.62 and a current ratio of 0.62. The company has a fifty day moving average of $262.79 and a 200 day moving average of $238.38. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.
Oracle (NYSE:ORCL – Get Free Report) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period in the prior year, the business earned $1.39 earnings per share. Oracle’s revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts anticipate that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is 46.30%.
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
- Five stocks we like better than Oracle
- Following Congress Stock Trades
- Bath & Body Works Hits Multi-Year Lows: Bargain or Trap?
- Bank Stocks – Best Bank Stocks to Invest In
- Worried About Inflation? These 3 ETFs Offer Real Protection
- High Flyers: 3 Natural Gas Stocks for March 2022
- Intel’s Black Friday Breakout: Apple Rumors Fuel a Holiday Rally
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
